Literature DB >> 3176300

A climate-based model for the development of the ixodid tick, Rhipicephalus appendiculatus in East Coast fever zones.

D King1, G Gettinby, R M Newson.   

Abstract

East Coast fever (Theileria parva infection) is an important parasitic disease of cattle in East and Central Africa. Past experimental studies have provided a great deal of information on the dynamics of the life cycle of the tick vector, Rhipicephalus appendiculatus. This paper describes a mathematical model based on field observations to explain the close relationship between the tick life cycle and climate. The model provides a basis for the future study of different ECF control programmes using computer experiments.

Entities:  

Mesh:

Year:  1988        PMID: 3176300     DOI: 10.1016/0304-4017(88)90006-4

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  4 in total

Review 1.  Parasitic adaptations in the transmission of Theileria by ticks--a review.

Authors:  A R Walker
Journal:  Trop Anim Health Prod       Date:  1990-02       Impact factor: 1.559

2.  Modelling the transmission dynamics of Theileria annulata: model structure and validation for the Turkish context.

Authors:  A J Sutton; T Karagenc; S Bakirci; H Sarali; G Pekel; G F Medley
Journal:  Parasitology       Date:  2012-02-06       Impact factor: 3.234

3.  Cattle ticks of the genera Rhipicephalus and Amblyomma of economic importance in Tanzania: distribution assessed with GIS based on an extensive field survey.

Authors:  Godelieve Lynen; Petr Zeman; Christine Bakuname; Giuseppe Di Giulio; Paul Mtui; Paul Sanka; Frans Jongejan
Journal:  Exp Appl Acarol       Date:  2007-11-27       Impact factor: 2.132

4.  Studies on the epidemiology of tropical theileriosis (Theileria annulata infection) in cattle in Central Anatolia, Turkey.

Authors:  F Sayin; S Dinçer; Z Karaer; A Cakmak; A Inci; B A Yukari; H Eren; Z Vatansever; S Nalbantoglu
Journal:  Trop Anim Health Prod       Date:  2003-12       Impact factor: 1.559

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.